Gilead Double-Patenting Ruling Is Routine, High Court Told
Natco Pharma Ltd. has urged the high court to reject Gilead Sciences Inc.'s bid to review a decision on double-patenting, saying the Federal Circuit's ruling that a patent was obvious in...To view the full article, register now.
Already a subscriber? Click here to view full article